Danaher Corporation (NYSE:DHR) is one of the stocks Jim Cramer shed light on. While discussing the stock’s condition over the ...

Danaher Corporation (NYSE:DHR) is one of the best strong buy healthcare stocks to buy now. On July 23, UBS lowered the firm’s ...

Danaher Corporation (NYSE:DHR) is a stock that Jim Cramer has a bittersweet relationship with. His trust has continued to ...

Danaher Corporation (NYSE:DHR) shareholders are probably feeling a little disappointed, since its shares fell 9.2% to US$223 in the week after its latest annual results.

Danaher Corporation (NYSE:DHR) last week reported its latest full-year results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations ...

Danaher's third quarter Compared to last year's third quarter, overall revenue increased 6.5%, comprising core revenue growth of 3% and contributions from acquisitions of 10.5%.

About a year ago, Danaher Corporation 's (NYSE: DHR) valuation looked cheap relative to its peers. Of course, when I write peers, I mean its medical, life sciences, and diagnostics peers because ...

We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against ...

--Danaher Corporation announced today that it has completed the separation of its Environmental& Applied Solutions segment, through the spin-off of Veralto Corporation. Veralto will begin "regular ...

Summary Danaher Corporation incorporates science and technology and has a market cap of $150B. The company has mixed financials, with its gross profit margin being its strongest and most consistent.

Danaher Corporation (DHR)’s share was trading at $202.62 as of 10 th June. DHR’s trailing and forward P/E were 38.6 and 26.39 respectively according to Yahoo Finance.